Clinical Trial Update: Prospectively Collected Pleural Biopsies for Validation of Malignant Pleural Mesothelioma Prognostic Biomarkers [NA]

View source ↗

Summary

A Dana-Farber Cancer Institute-led trial is recruiting to validate prognostic biomarkers for malignant pleural mesothelioma using prospectively collected pleura…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Mesothelioma

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Mesothelioma | NA | Status: RECRUITING